Peer review reports
From: QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CLpro inhibitors
Original Submission | ||
---|---|---|
23 Nov 2022 | Submitted | Original manuscript |
5 Dec 2022 | Reviewed | Reviewer Report |
4 Mar 2023 | Author responded | Author comments - Shahin Ahmadi |
Resubmission - Version 2 | ||
4 Mar 2023 | Submitted | Manuscript version 2 |
6 Mar 2023 | Author responded | Author comments - Shahin Ahmadi |
Resubmission - Version 3 | ||
6 Mar 2023 | Submitted | Manuscript version 3 |
Publishing | ||
31 Mar 2023 | Editorially accepted | |
7 Apr 2023 | Article published | 10.1186/s13065-023-00947-w |